News & Analysis as of

Abbreviated New Drug Application (ANDA) › Regulatory Reform › Pharmacies

McDermott Will & Emery

FDA Publishes Proposed Rule on Sections 503A and 503B Compounding

McDermott Will & Emery on

On March 20, 2024, the US Food & Drug Administration (FDA) issued a proposed rule titled Drug Products or Categories of Drug Products that Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide